sevelamer carbonate 0.8 GM Powder for Oral Suspension
- RxCUI
- 861375
- RxNorm name
- sevelamer carbonate 0.8 GM Powder for Oral Suspension
- Display name
- sevelamer carbonate 0.8 GM Powder for Oral Suspension
- Full name
- sevelamer carbonate 0.8 GM Powder for Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:25
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | NorthStar RxLLC | 5baf3742-5929-42f8-8865-6b3e92647d5b | 2026-07-16 | Warnings, Adverse reactions | 861375 |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Sanofi-Aventis U.S. LLC | 3abc32fe-1bfc-4759-8f7c-36095e221b06 | 2025-11-25 | Warnings, Adverse reactions | 861375 |
| Renvela | SEVELAMER CARBONATE | Genzyme Corporation | e6328460-a57b-450b-a48c-6dcd4b476360 | 2025-11-25 | Warnings, Adverse reactions | 861375 |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Macleods Pharmaceuticals Limited | 48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 | 2025-09-26 | Warnings, Adverse reactions | 861375 |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Strides Pharma Science Limited | c17bff97-8347-43f8-822e-1cb9736562b6 | 2025-07-09 | Warnings, Adverse reactions | 861375 |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Bionpharma Inc. | c3cf4807-ae5f-528e-e053-2a95a90ac640 | 2024-08-22 | Warnings, Adverse reactions | 861375 |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Aurobindo Pharma Limited | ea201bff-cdfb-4304-bdb1-d05c1dac2677 | 2023-12-08 | Warnings, Adverse reactions | 861375 |
| sevelamer carbonate | SEVELAMER CARBONATE | Amneal Pharmaceuticals of New York LLC | da5239fe-060b-4469-95ac-173adec43b9c | 2020-12-31 | Warnings, Adverse reactions | 861375 |
| Sevelamer Carbonate for Oral Suspension | SEVELAMER CARBONATE FOR ORAL SUSPENSION | Dr. Reddys Laboratories Inc | de172c3d-17eb-3489-35fb-370a0893b663 | 2020-05-20 | Warnings, Adverse reactions | 861375 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e6328460-a57b-450b-a48c-6dcd4b476360 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 47 | These highlights do not include all the information needed to use RENVELA safely and effectively. See full prescribing information for RENVELA. RENVELA (sevelamer carbonate) tablets, for oral use RENVELA (sevelamer carbonate) powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| e6328460-a57b-450b-a48c-6dcd4b476360 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 47 | These highlights do not include all the information needed to use RENVELA safely and effectively. See full prescribing information for RENVELA. RENVELA (sevelamer carbonate) tablets, for oral use RENVELA (sevelamer carbonate) powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| e6328460-a57b-450b-a48c-6dcd4b476360 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 47 | These highlights do not include all the information needed to use RENVELA safely and effectively. See full prescribing information for RENVELA. RENVELA (sevelamer carbonate) tablets, for oral use RENVELA (sevelamer carbonate) powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| 3abc32fe-1bfc-4759-8f7c-36095e221b06 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 20 | These highlights do not include all the information needed to use SEVELAMER CARBONATE safely and effectively. See full prescribing information for SEVELAMER CARBONATE. SEVELAMER CARBONATE tablets, for oral use SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| 3abc32fe-1bfc-4759-8f7c-36095e221b06 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 20 | These highlights do not include all the information needed to use SEVELAMER CARBONATE safely and effectively. See full prescribing information for SEVELAMER CARBONATE. SEVELAMER CARBONATE tablets, for oral use SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| 3abc32fe-1bfc-4759-8f7c-36095e221b06 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 20 | These highlights do not include all the information needed to use SEVELAMER CARBONATE safely and effectively. See full prescribing information for SEVELAMER CARBONATE. SEVELAMER CARBONATE tablets, for oral use SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20251125 |
| da5239fe-060b-4469-95ac-173adec43b9c | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 11 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20201231 |
| da5239fe-060b-4469-95ac-173adec43b9c | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 11 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20201231 |
| da5239fe-060b-4469-95ac-173adec43b9c | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 11 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20201231 |
| ea201bff-cdfb-4304-bdb1-d05c1dac2677 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 9 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20231208 |
| ea201bff-cdfb-4304-bdb1-d05c1dac2677 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 9 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20231208 |
| ea201bff-cdfb-4304-bdb1-d05c1dac2677 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 9 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20231208 |
| c17bff97-8347-43f8-822e-1cb9736562b6 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20240223 |
| c17bff97-8347-43f8-822e-1cb9736562b6 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20240223 |
| c17bff97-8347-43f8-822e-1cb9736562b6 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE for oral suspension Initial U.S. Approval: 2000 | 20240223 |
| 8ef0cb12-e9f6-4865-9158-02c8cc50a511 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20230324 |
| 8ef0cb12-e9f6-4865-9158-02c8cc50a511 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20230324 |
| 8ef0cb12-e9f6-4865-9158-02c8cc50a511 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 6 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20230324 |
| c3cf4807-ae5f-528e-e053-2a95a90ac640 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20240822 |
| c3cf4807-ae5f-528e-e053-2a95a90ac640 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20240822 |
| c3cf4807-ae5f-528e-e053-2a95a90ac640 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE powder, for oral suspension Initial U.S. Approval: 2000 | 20240822 |
| de172c3d-17eb-3489-35fb-370a0893b663 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE , for oral suspension Initial U.S. Approval: 2000 | 20200520 |
| de172c3d-17eb-3489-35fb-370a0893b663 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE , for oral suspension Initial U.S. Approval: 2000 | 20200520 |
| de172c3d-17eb-3489-35fb-370a0893b663 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 3 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION . SEVELAMER CARBONATE , for oral suspension Initial U.S. Approval: 2000 | 20200520 |
| 48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 2 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20250926 |
| 48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 2 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20250926 |
| 48dbd7a7-32c7-45c1-ac8b-c478cf3282a6 | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 2 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20250926 |
| 5baf3742-5929-42f8-8865-6b3e92647d5b | sevelamer carbonate 800 MG Powder for Oral Suspension | SCD | 1 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20241206 |
| 5baf3742-5929-42f8-8865-6b3e92647d5b | sevelamer carbonate 0.8 GM Powder for Oral Suspension | PSN | 1 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20241206 |
| 5baf3742-5929-42f8-8865-6b3e92647d5b | sevelamer carbonate 0.8 GM Powder for Oral Suspension | SY | 1 | These highlights do not include all the information needed to use SEVELAMER CARBONATE FOR ORAL SUSPENSION safely and effectively. See full prescribing information for SEVELAMER CARBONATE FOR ORAL SUSPENSION. SEVELAMER CARBONATE, for oral suspension Initial U.S. Approval: 2000 | 20241206 |